24 completed, 20 recruiting, 9 terminated, 7 not yet recruiting. 69 Phase 1, 28 Phase 2.
Follow Purpura: new trials by email Literature Review of Purpura trials Research Report on Purpura
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 Dose Escalation Study of RXIM002 in Autoimmune Cytopenias RXIM002 - Immune Thrombocytopenia (ITP) | Phase 1 | Not yet recruiting | RiboX Therapeutics Ltd. | 27 | 2027-02-01 | 2026-10-28 |
| An Open-label Phase I/II Safety and Feasibility Basket Study of UKT-CART19.1 CAR-T cells targeting CD19 - Pemphigus Vulgaris (PV), ANCA Associated Vasculitis (AAV) | Phase 1 / Phase 2 | Not yet recruiting | University Hospital Tuebingen | 36 | 2027-01-01 | 2026-11-12 |
| A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA Velinotamig specified dose on specified days. - Immune Thrombocytopenia (ITP), Warm Autoimmune Hemolytic Anemia (WAIHA) | Phase 1 / Phase 2 | Not yet recruiting | Cullinan Therapeutics Inc. | 72 | 2026-12-01 | 2026-07-31 |
| TGD001 Treatment in Thrombotic Microangiopathies TGD001 - Thrombotic Microangiopathies, ITP Immune-Mediated Thrombocytopenia | Phase 1 / Phase 2 | Recruiting | TargED Biopharmaceuticals B.V. | 70 | 2026-10-25 | 2026-11-12 |
| Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease CTX112 - Warm Autoimmune Hemolytic Anemia (WAIHA), ITP - Immune Thrombocytopenia | Phase 1 / Phase 2 | Recruiting | CRISPR Therapeutics AG | 60 | 2026-07-17 | 2026-10-20 |
| Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed Conditions SKI-O-703 API in Capsules, SKI-O-703 Formulated Granules in Capsules - Bioequivalence Study in Healthy Subjects, Immune Thrombocytopenia (ITP) | Phase 1 | Active not recruiting | Oscotec Inc. | 48 | 2026-07-10 | 2026-09-01 |
| A Clinical Study to Evaluate JCXH-213 in the Treatment of Adults With Primary Immune Thrombocytopenia JCXH-213 - Thrombocytopenic Purpura, Immune | Phase 1 | Not yet recruiting | The General Hospital of Western Theater Command | 4 | 2026-06-18 | 2026-06-03 |
| CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related Cytopenia Anti-CD20 monoclonal antibody and the BTK inhibitor - Anti-CD20 Monoclonal Antibody, BTK Inhibitors | Phase 1 | Not yet recruiting | Qi deng | 30 | 2026-06-01 | 2026-05-22 |
| Universal STAR-T Cell Injection in R/R Autoimmune Diseases. Universal STAR-T Cell - Immune Thrombocytopenia | Phase 1 | Not yet recruiting | Jian Zhu | 6 | 2026-05-11 | 2026-05-20 |
| Safety and Efficacy of GL-2045 in Patients With Immune Thrombocytopenia GL-2045 - Immune Thrombocytopenia | Phase 1 | Recruiting | Gliknik Inc. | 42 | 2026-04-14 | 2026-05-26 |
| A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia CM336 Injection - Autoimmune Cytopenia, Immune Thrombocytopenia (ITP) | Phase 1 / Phase 2 | Recruiting | Keymed Biosciences Co.Ltd | 158 | 2025-11-18 | 2025-12-17 |
| Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia SHR-2173 Injection - Immune Thrombocytopenia | Phase 1 | Recruiting | Guangdong Hengrui Pharmaceutical Co., Ltd | 10 | 2025-11-12 | 2026-05-28 |
| An Exploratory Study of Golidocitinib in Adult Patients With ITP Golidocitinib, Placebo - Immune Thrombocytopenia (ITP) | Phase 1 / Phase 2 | Not yet recruiting | Peking University People's Hospital | 138 | 2025-10-30 | 2025-09-29 |
| OM336 in Autoimmune Cytopenias OM336 - AIHA - Warm Autoimmune Hemolytic Anemia, AIHA - Cold Autoimmune Hemolytic Anemia | Phase 1 | Recruiting | Lakefront Biotherapeutics West LLC | 32 | 2025-08-01 | 2026-09-03 |
| A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia Pirtobrutinib, Placebo - Immune Thrombocytopenia (ITP) | Phase 1 / Phase 2 | Recruiting | Eli Lilly and Company | 68 | 2025-07-30 | 2026-11-04 |
| RN1201 Injection in the Treatment of Antibody-Mediated Diseases CD19 and BCMA-targeted allogeneic CAR-T cells - Refractory Immune-mediated Platelet Transfusion Refractoriness, Relapsed or Refractory Immune Thrombocytopenia | Phase 1 | Recruiting | The First Affiliated Hospital of Soochow University | 9 | 2025-07-07 | 2026-06-12 |
| A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP) Budoprutug - Immune Thrombocytopenia (ITP), ITP | Phase 1 / Phase 2 | Recruiting | Climb Bio, Inc. | 24 | 2025-06-30 | 2026-03-27 |
| A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP) STSA-1301 subcutaneous injection, Placebo - Primary Immune Thrombocytopenia (ITP) | Phase 1 / Phase 2 | Recruiting | Jiangsu BioJeTay Biotechnology Co., Ltd. | 56 | 2025-05-12 | 2026-08-12 |
| A Phase 1/2 Study of ESG206 in Patients With Primary Immune Thrombocytopenia ESG206 - Immune Thrombocytopenia (ITP) | Phase 1 / Phase 2 | Recruiting | Shanghai Escugen Biotechnology Co., Ltd | 84 | 2025-05-08 | 2025-05-16 |
| A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus YTS109 cell injection - Lupus Nephritis (LN), Immune Thrombocytopenia (ITP) | Phase 1 | Terminated | China Immunotech (Beijing) Biotechnology Co., Ltd. | 2 | 2025-04-16 | 2026-10-14 |
Showing 20 of 69. Sign in to see all of them.
Purpura, Thrombocytopenic, Idiopathic (63) · Thrombocytopenia (7) · Anemia, Hemolytic, Autoimmune (5) · Autoimmune Diseases (4) · Anemia, Hemolytic (3) · Arthritis, Rheumatoid (3) · Blood Platelet Disorders (3) · Hematologic Diseases (3) · Purpura, Thrombocytopenic (3) · Antiphospholipid Syndrome (2) · Behcet Syndrome (2) · Dermatomyositis (2) · Evans Syndrome (2) · Immune System Diseases (2)
Hemic and Lymphatic Diseases (69) · Pathological Conditions, Signs and Symptoms (69) · Signs and Symptoms (69) · Blood Coagulation Disorders (68) · Hemorrhage (68) · Pathologic Processes (68) · Skin Manifestations (68) · Hematologic Diseases (66) · Cytopenia (65) · Blood Platelet Disorders (63) · Hemorrhagic Disorders (62) · Thrombotic Microangiopathies (62) · Immune System Diseases (61) · Purpura, Thrombocytopenic (61)
eltrombopag (8) · Rituximab (3) · Staphylococcal Protein A (3) · romiplostim (3) · Tablets (2) · avatrombopag (2) · Acetaminophen (1) · Acetylcysteine (1) · Antigens, CD19 (1) · Atorvastatin (1) · BI 655064 (1) · CD4 Immunoadhesins (1) · Capsules (1) · Ciprofloxacin (1) · Cyclosporine (1)
GlaxoSmithKline (6) · Eisai Inc. (4) · Peking University People's Hospital (4) · Protalex, Inc. (3) · Amgen (2) · Chongqing Peg-Bio Biopharm Co., Ltd. (2) · Chugai Pharmaceutical (2) · Jiangsu HengRui Medicine Co., Ltd. (2) · 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China (1) · Alpine Immune Sciences Inc, A Subsidiary of Vertex (1) · Baylor College of Medicine (1) · Bioverativ, a Sanofi company (1) · Boehringer Ingelheim (1) · Bristol-Myers Squibb (1) · CASI pharmaceuticals, Inc. (1)
United States (28) · China (25) · Spain (10) · United Kingdom (10) · Australia (8) · Germany (7) · Italy (5) · Norway (5) · Poland (5) · Canada (4) · France (4) · Netherlands (4) · Austria (3) · Bulgaria (3) · Hungary (3)
Franklin Johnson (2) · Ann-Christin Pecher (1) · Bhaskar Rege (1) · David T. Teachey, MD (1) · Edo Scahefer, MD (1) · Edward Bernton, MD (1) · Ellis J Neufeld, MD, PhD (1)
PMID 19208097, PMID 19846889, PMID 23829485, PMID 24802773, PMID 26504182, PMID 27515248, PMID 29270980, PMID 30171280, PMID 30344993, PMID 32865293, PMID 34452956, PMID 34921514, PMID 35973190, PMID 37028433, PMID 42056497
2014 (2), 2018 (2), 2023 (1), 2025 (1)